Acute phase response, inflammation and metabolic syndrome biomarkers of Libby asbestos exposure
Jonathan H. Shannahan1, Oscar Alzate2, Witold M. Winnik3, Debora Andrews3, Mette C. Schladweiler4, Andrew J. Ghio5, Stephen H. Gavett4, Urmila P. Kodavanti4
1Curriculum in Toxicology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA
2Systems Proteomics Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA
3Proteomics Core, Research Core Unit, National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA
4Cardiopulmonary and Immunotoxicology Branch, Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA
5Clinical Research Branch, Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Chapel Hill, NC 27599, USA
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Toxicology and Applied Pharmacology
Tập 260
105-114
Thông tin tác giả